Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Trentin, Livio
RAFTING, NCT04866654 / 2020-002382-33: Radiation Free Chemotherapy for Early Hodgkin Lymphoma	Recruiting	2	160	Europe	Nivolumab 10 MG/ML	Medical University of Gdansk, Medical Research Agency	Hodgkin Lymphoma	09/22	07/26
NCT03552003: Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis	Recruiting	N/A	400	Europe	Treatment for clinical practise	Fondazione Italiana Linfomi ONLUS	Classical Hodgkin Lymphoma	01/26	01/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Trentin, Livio
RAFTING, NCT04866654 / 2020-002382-33: Radiation Free Chemotherapy for Early Hodgkin Lymphoma	Recruiting	2	160	Europe	Nivolumab 10 MG/ML	Medical University of Gdansk, Medical Research Agency	Hodgkin Lymphoma	09/22	07/26
NCT03552003: Study for Elderly (≥ 65 Years) Patients With Classical Hodgkin Lymphoma Undergoing CGA at Diagnosis	Recruiting	N/A	400	Europe	Treatment for clinical practise	Fondazione Italiana Linfomi ONLUS	Classical Hodgkin Lymphoma	01/26	01/26